Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Harrison, Roger
One or more keywords matched the following items that are connected to Harrison, Roger
Item TypeName
Concept Annexin A5
Concept Annexin A1
Academic Article Annexin V-targeted enzyme prodrug therapy using cytosine deaminase in combination with 5-fluorocytosine.
Academic Article Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature.
Academic Article Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide.
Academic Article A soluble tissue factor-annexin V chimeric protein has both procoagulant and anticoagulant properties.
Academic Article Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature.
Academic Article Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.
Academic Article Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.
Academic Article Anionic phospholipid expression as a molecular target in Listeria monocytogenes and Escherichia coli.
Academic Article Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer.
Academic Article Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy.
Academic Article Annexin-directed ß-glucuronidase for the targeted treatment of solid tumors.
Academic Article Annexin A5 as a targeting agent for cancer treatment.
Academic Article Annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer.
Academic Article Correction: annexin A5-DM1 protein-drug conjugate for the treatment of triple-negative breast cancer.
Search Criteria
  • Annexin A5